The Arizona Telemedicine Program at the University of Arizona Health Sciences has been awarded $828,000 in federal funds to help communities expand telehealth programs during the ongoing coronavirus pandemic.

The University of Arizona Sarver Heart Center director will co-lead the innovative program with Dr. Ronald Hammer to match students with faculty mentors to train in research design and methodology, biostatistics and responsible conduct of research relevant to human health and disease.

As the spread of COVID-19 affects people around the world, scientists have been working overtime to develop potential treatments. Among them is a Jun Wang, Ph.D., an assistant professor of pharmacology and toxicology at the University of Arizona who recently identified four compounds that can block the replication of the virus within a cell, providing a promising starting point for the development of drugs that can treat the disease.

The National Library of Medicine recommends adding these titles to your reading list during Mental Health Awareness Month this May.

In the fall, students will be able to dive headfirst into design thinking, a creative process for solving real-world problems.

Findings on compounds blocking SARS-COV-2 viral replication may offer a starting point for further development of treatments to address the ongoing, devastating novel coronavirus pandemic.

The College of Medicine – Phoenix is helping evaluate the quality of the research being released rapidly about the virus that causes COVID-19.

After finishing his degree at the University of Arizona as a doctor in pharmacy, Jeffrey Asman, 56, said the decision to go back to school in his “second half of life” was an easy one. “I was 48 or 49 wondering if my old college credits were any good. It is cliché to say but really true that it is never too late.”